Financial Architects (New Jersey)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Financial Architects (New Jersey)’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-300	Closed	-$35K	–	1027
2019 Q3	$35K	Buy	+300	New	+$45.5K	0.01%	498
2019 Q2	–	Sell	-200	Closed	-$34K	–	1554
2019 Q1	$34K	Hold	200	–	–	0.01%	730
2018 Q4	$19K	Buy	+200	New	+$26.2K	﹤0.01%	821

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Financial Architects (New Jersey)'s GWPH Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 200 shares — an estimated $25K sold.

Financial Architects (New Jersey) first reported a position in GWPH in Q4 2014 and held it in 20 quarters. The position peaked at $92K in Q3 2018. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

Financial Architects (New Jersey) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Financial Architects (New Jersey) sold 200 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $25K.
Financial Architects (New Jersey) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 20 quarters.
Financial Architects (New Jersey)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $92K in Q3 2018.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.